Change
Tools: Print this page Recommend this page

Consolidated statement of income


2ND QUARTER

 

IN € MILLIONS

JANUARY - JUNE

2010

20091

 

 

2010

20091

1

Restated for comparative presentation.

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

3,907

3,450

 

Revenue

7,153

6,515

(2,254)

(2,027)

 

Cost of sales

(4,165)

(3,902)

1,653

1,423

 

Gross profit

2,988

2,613

 

 

 

 

 

 

(859)

(789)

 

Selling expenses

(1,631)

(1,522)

(259)

(261)

 

General and administrative expenses

(514)

(530)

(85)

(86)

 

Research and development expenses

(162)

(163)

5

24

 

Other operating income/(expenses)

(2)

23

455

311

 

Operating income

679

421

 

 

 

 

 

 

(113)

(85)

 

Net financing expenses

(201)

(190)

7

6

 

Results from associates and joint ventures

12

10

349

232

 

Profit before tax

490

241

 

 

 

 

 

 

(76)

(71)

 

Income tax

(129)

(76)

273

161

 

Profit for the period from continuing operations

361

165

 

 

 

 

 

 

 

 

 

Discontinued operations

 

 

26

14

 

Profit for the period from discontinued operations

37

21

 

 

 

 

 

 

299

175

 

Profit for the period

398

186

 

 

 

 

 

 

 

 

 

Attributable to:

 

 

273

155

 

- Shareholders of the company

354

148

26

20

 

- Minority interests

44

38

 

 

 

 

 

 

299

175

 

Profit for the period

398

186

 

 

 

 

 

 

 

 

 

Earnings per share from continuing operations (in €):

 

 

1.06

0.61

 

- Basic

1.36

0.55

1.05

0.60

 

- Diluted

1.35

0.54

 

 

 

 

 

 

 

 

 

Earnings per share from discontinued operations (in €):

 

 

0.11

0.06

 

- Basic

0.16

0.09

0.11

0.06

 

- Diluted

0.16

0.09

 

 

 

 

 

 

 

 

 

Earnings per share from total operations (in €):

 

 

1.17

0.67

 

- Basic

1.52

0.64

1.16

0.66

 

- Diluted

1.51

0.63

Copyright © 2010 Akzo Nobel N.V.